This image shows the replication cycle of HIV/SIV. The virus replicates in the body's own CD4+ T helper cells. In doing so, it introduces its own genetic information into the DNA of the host cell.

In particular, miR29 plays a key role in controlling the HIV life cycle. ... When either was altered, miR29s suppression of HIV replication and infectivity was reduced or eliminated.

Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...

A new antiretroviral target has been identified that suppresses HIV-1 replication and selectively kills HIV-1-infected cells. A collaboration of researchers led by Johns Hopkins University and the US ...

"Even after four decades of research, there are still parts of the HIV replication cycle we do not understand. These studies add critical knowledge of how HIV replicates," says Freed.

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

For instance, Yang, C., Liu, D., and colleagues used recombinant HIV capsid protein p24 (Sino Biological ) and an HIV-1 p24 ELISA Pair Set to develop a gold nanorod (AuNR)-based microfluidic ...

The siRNAs interrupted early events in the HIV replication cycle by directing the specific degradation of genomic HIV-1 RNA. This prevented subsequent synthesis of viral reverse-transcription ...